Polymeric Micelles, a Promising Drug Delivery System to Enhance Bioavailability of Poorly Water-Soluble Drugs
Open accessThe DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Abstract
Oral administration is the most commonly used and readily accepted form of drug delivery; however, it is find that many drugs are difficult to attain enough bioavailability when administered via this route. Polymeric micelles (PMs) can overcome some limitations of the oral delivery acting as carriers able to enhance drug absorption, by providing (1) protection of the loaded drug from the harsh environment of the GI tract, (2) release of the drug in a controlled manner at target sites, (3) prolongation of the residence time in the gut by mucoadhesion, and (4) inhibition of efflux pumps to improve the drug accumulation. To explain the mechanisms for enhancement of oral bioavailability, we discussed the special stability of PMs, the controlled release properties of pH-sensitive PMs, the prolongation of residence time with mucoadhesive PMs, and the P-gp inhibitors commonly used in PMs, respectively. The primary purpose of this paper is to illustrate the potential of PMs for delivery of poorly water-soluble drugs with bioavailability being well maintained.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Schematic representation of the mechanisms involved in the absorption of exogenous drugs in the small intestine. (a) Transcellular transport; (b) active transport; (c) facilitated diffusion; (d) receptor-mediated endocytosis; (e) paracellular transport; (f) pinocytosis [3].](https://figures.cochat.ai/paper-figures/f760f35972f34f1c8e324112b058d11c/polymeric-micelles-a-promising-drug-delivery-system-to-enhance-bioavailability-figure-1.jpg)


![Figure 4 Pluronic block copolymers available from BASF (Wyandotte, MI, USA) contain two hydrophilic EO blocks and a hydrophobic PO block [167].](https://figures.cochat.ai/paper-figures/292163f5bd3e4a15b3eb9e18032f118f/polymeric-micelles-a-promising-drug-delivery-system-to-enhance-bioavailability-figure-4.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ABC Transporters: From Microorganisms to Man
Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985 · cited 3×
“Pgp is a 170-kDa membrane transporter which is part of the ATP-binding cassette (ABC) [150].”
BackgroundSolid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759 · cited 2×
“Several strategies have been proposed such as micronization, complexation, formation of solid solutions, microemulsification, and novel drug delivery systems, including nanoparticles, lipid-based vesicles, and micelles [15–18].”
BackgroundDrug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734 · cited 1×
“Besides, approximately 40% of currently marketed immediate-release oral drugs are considered practically insoluble (solubility less than 100 μg/mL) in water [6, 7].”
BackgroundImpact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348 · cited 2×
“macromolecules [12, 13].”
A review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155 · cited 2×
“Blends of this polymer with polyethylacrylate (PMAA-PEA) and polymethacrylate (PMAA-PMA) can be tailored to dissolve in specific pH ranges corresponding to specific locations in the GI tract [100–102].”
BackgroundMicellization of block copolymers
Riess, G. (2003) · Progress in Polymer Science · doi:10.1016/s0079-6700(03)00015-7 · Cited by 1,953 · cited 1×
“PMs are self-assembled core-shell nanostructures formed in an aqueous solution consisting of amphiphilic block copolymers (see Figure 2) [35, 36].”
BackgroundMucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815 · cited 1×
“Mucoadhesion can be obtained by the building of either nonspecific interactions with the mucosal surface, such as covalent bonds, ionic bonds, hydrogen bonding, and van der Waals’ interactions [117], or specific interactions by functionalizing polymers with targeting ligands (e.”
BackgroundOral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623 · cited 1×
“Intrinsic properties of drugs such as poor stability in the gastric environment, lowmucosal permeability, and low solubility in the mucosal fluids will contribute to low absorption [26, 27].”
BackgroundPluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00009-3 · Cited by 1,474 · cited 3×
“Poly(propylene oxide) (PPO) [53, 59] which belongs to Pluronics, poly(esters) such as poly(lactic acid) (PLA) [60], hydrophobic poly(amino acids) [61], copolymers of lactic acid and glycolic acids [62, 63], and poly(caprolactone) (PCL) [64], which are regarded as the”
BackgroundMethodCone, R. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459 · cited 1×
“The luminal surface of mucosal tissues is protected by a highly viscoelastic layer [110], and the protective coatings rapidly remove foreign particles from the GI tract which probably lead to low bioavailability.”
Background
Research works printed but not linked: 2
- Lee ES Shin HJ Na K Bae YH Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization Journal of Controlled Release 2003 90 3 363 374 2-s2.0-0038106270 12880703 · DOI · Paper page
- Mo R Jin X Li N The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles Biomaterials 2011 32 20 4609 4620 2-s2.0-79955522520 21440934 · DOI · Paper page
Cited by
Items 101–200 of 620
Topical formulation of self-assembled antiviral prodrug nanomicelles for targeted retinal delivery
Mandal, A., Cholkar, K., Khurana, V., Shah, A., Agrahari, V., Bisht, R., Pal, D., & Mitra, A. K. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00128 · Cited by 60
Oral Drug Delivery: Conventional to Long Acting New-Age Designs
Bhutani, U., Basu, T., & Majumdar, S. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.02.008 · Cited by 64
Preclinical Cancer Theranostics—From Nanomaterials to Clinic: The Missing Link
Johnson, K. K., Koshy, P., Yang, J., & Sorrell, C. C. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202104199 · Cited by 60
Li, L., Zeng, Y., Chen, M., & Liu, G. (2022) · Polymers · doi:10.3390/polym14163278 · Cited by 64
Chen, Y., Liu, F., Pal, S., & Hu, Q. (2024) · Chemical Society Reviews · doi:10.1039/d4cs00411f · Cited by 61
Conjugates and nano-delivery of antimicrobial peptides for enhancing therapeutic activity
Faya, M. A., Kalhapure, R. S., Kumalo, H. M., Waddad, A. Y., Omolo, C. A., & Govender, T. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.12.010 · Cited by 60
Nanoparticle-based drug delivery systems to overcome gastric cancer drug resistance
Nejati‐Koshki, K., Rastegar, M., Fathi, F., Dadashpour, M., & Arabzadeh, A. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103231 · Cited by 65
Elezaby, R. S., Gad, H. A., Metwally, A. A., Geneidi, A. S., & Awad, G. A. S. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.06.019 · Cited by 60
Recent Advances in Oral Mucoadhesive Drug Delivery
Golshani, S., Vatanara, A., & Amin, M. (2022) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps32705 · Cited by 58
“Sugars are present in glycolipids and glycoproteins of mammalian mucosa, at the surface of epithelial cells, or in mucous layers (4).”
BackgroundInfluentialMicroemulsion Based Nanostructures for Drug Delivery
Arredondo-Ochoa, T., & Silva-Martínez, G. A. (2022) · Frontiers in Nanotechnology · doi:10.3389/fnano.2021.753947 · Cited by 59
“PMs, with diameters ranging from 10 to 100 nm, are self-assembled nanostructures formed in aqueous solutions characterized by a core–shell structure; the inner core is composed of the hydrophobic regions which encapsulates the poorly water-soluble drug, whereas the outer shell or corona of the hydrophilic block of the…”
BackgroundPolymeric nano-micelles: Versatile Platform for Targeted Delivery in Cancer
Mohamed, S. E.-S. H., Parayath, N. N., Taurin, S., & Greish, K. F. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.69 · Cited by 61
Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines
Mallapragada, S. K., Brenza, T. M., McMillan, J., Narasimhan, B., Sakaguchi, D. S., Sharma, A. D., Zbarska, S., & Gendelman, H. E. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.12.013 · Cited by 58
“Some important parameters that affect the stability of micellar carriers include lengths of the hydrophobic and hydrophilic blocks, chemical nature and molecular weight of hydrophilic blocks, physical state (amorphous or crystalline) of core forming polymer, pH sensitivity, interaction of micelle with serum proteins,…”
Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases
Smith, J. A., Leonardi, T., Huang, B., Iraci, N., Vega, B., & Pluchino, S. (2015) · Biogerontology · doi:10.1007/s10522-014-9510-7 · Cited by 54
“…polymersomal EMV analogues (Akbarzadeh et al. 2013; Christian et al. 2009; Lee and Feijen 2012; Theresa and Pieter 2013), micelles (Deng et al. 2012; Xu et al. 2013), polymer, protein and lipid complexes (Zia ur et al. 2013; Wasungu and Hoekstra 2006; Ge et al. 2012; Zhang et al. 2012),…”
BackgroundInfluentialPhytoconstituent plumbagin: Chemical, biotechnological and pharmaceutical aspects
Badwaik, H. R., Kumari, L., Nakhate, K. T., Verma, V. S., & Sakure, K. (2019) · Studies in natural products chemistry · doi:10.1016/b978-0-12-817901-7.00013-7 · Cited by 62
Akash, S., Aovi, F. I., Azad, A., Kumer, A., Chakma, U., Islam, M. R., Mukerjee, N., Rahman, M. M., Bayıl, İ., Rashid, S., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283271 · Cited by 54
Grilc, N. K., Sova, M., & Kristl, J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122137 · Cited by 57
“, P-glycoprotein) in the intestinal wall [176,177].”
Targeting the Gut: A Systematic Review of Specific Drug Nanocarriers
Garbati, P., Picco, C., Magrassi, R., Signorello, P., Cacopardo, L., Serra, M. D., Faticato, M. G., Luca, M. D., Balestra, F., Scavo, M. P., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16030431 · Cited by 60
“In such a disease, several membrane proteins are known to be overexpressed and can be used as targets to enable specific drug delivery.”
BackgroundOrdanini, S., & Cellesi, F. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040209 · Cited by 52
“As complex polymeric architectures may self-assemble forming stable unimolecular micelles, they can encapsulate and transport poorly soluble hydrophobic drugs, enhancing the therapeutic efficacy and reducing the side effects in vivo [52].”
BackgroundSolvent Emulsification Evaporation and Solvent Emulsification Diffusion Techniques for Nanoparticles
Chaudhary, S. A., Patel, D. M., Patel, J. K., & Patel, D. H. (2021) · Springer eBooks · doi:10.1007/978-3-030-50703-9_12 · Cited by 72
Tsatsakis, A., Stratidakis, A. K., Goryachaya, A. V., Tzatzarakis, M. N., Stivaktakis, P. D., Docea, A. O., Berdiaki, A., Nikitovic, D., Velonia, K., Shtilman, M. I., et al. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.02.041 · Cited by 52
Maiti, B., Dey, N., & Bhattacharya, S. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00083 · Cited by 50
Nanocarriers as Potential Targeted Drug Delivery for Cancer Therapy
Singhvi, G., Rapalli, V. K., Nagpal, S., Dubey, S. K., & Saha, R. N. (2020) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-030-29207-2_2 · Cited by 57
Meng, Q., Zhong, S., He, S., Gao, Y., & Cui, X. (2021) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2021.09.021 · Cited by 50
Jafari, M., Abolmaali, S. S., Najafi, H., & Tamaddon, A. M. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118959 · Cited by 48
Shivhare, K., Garg, C., Priyam, A., Gupta, A. D., Sharma, A. K., & Kumar, P. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.08.071 · Cited by 47
Engineering Nanomaterials for Smart Drug Release
Singh, A. K., Yadav, T. P., Pandey, B., Gupta, V., & Singh, S. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814029-1.00015-6 · Cited by 60
Current advanced drug delivery systems: Challenges and potentialities
Ragib, A. A., Chakma, R., Dewan, K., Islam, T., Kormoker, T., & Idris, A. M. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103727 · Cited by 52
Chaemsawang, W., Prasongchean, W., Papadopoulos, K. I., Ritthidej, G. C., Sukrong, S., & Wattanaarsakit, P. (2019) · International Journal of Biomaterials · doi:10.1155/2019/9404383 · Cited by 46
Current Trends in Drug Delivery System of Curcumin and its Therapeutic Applications
Sethiya, A., Agarwal, D. K., & Agarwal, S. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200429103647 · Cited by 47
Zeyada, M. S., Abdel‐Rahman, N., El-Karef, A. A., Yahia, S., El-sherbiny, I. M., & Eissa, L. A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118458 · Cited by 48
Nanomedicine Scale-Up Technologies: Feasibilities and Challenges
Patel, D. M., Patel, N. N., & Patel, J. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-50703-9_24 · Cited by 69
Polymer mechanochemistry in drug delivery: From controlled release to precise activation
Shi, Z., Hu, Y. M., & Li, X. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.10.042 · Cited by 51
Drug Delivery Systems Based on Pluronic Micelles with Antimicrobial Activity
Popovici, C., Popa, M., Şunel, V., Atanase, L. I., & Ichim, D. L. (2022) · Polymers · doi:10.3390/polym14153007 · Cited by 45
The Good and the Bad of Cell Membrane Electroporation
Balantič, K., Miklavčič, D., Križaj, I., & Kramar, P. (2021) · Acta chimica slovenica · doi:10.17344/acsi.2021.7198 · Cited by 46
de Oliveira, A. L. B., Cavalcante, F. T. T., Moreira, K. S., Monteiro, R. R. C., Rocha, T. G., Souza, J. E. S., da Fonseca, A. M., Lopes, A. A. S., Guimarães, A. P., de Lima, R. K. C., et al. (2021) · Revista Virtual de Química · doi:10.21577/1984-6835.20210019 · Cited by 44
Kim, J., Shamul, J. G., Shah, S. R., Shin, A., Lee, B. J., Quinones-Hinojosa, A., & Green, J. J. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00640 · Cited by 44
Rahmani, A., Rahimi, F., Iranshahi, M., Kahroba, H., Zarebkohan, A., Talebi, M., Salehi, R., & Mousavi, H. Z. (2021) · Scientific Reports · doi:10.1038/s41598-021-00954-8 · Cited by 43
Marsili, L., Bo, M. D., Berti, F., & Toffoli, G. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111876 · Cited by 44
Therapeutic potential of nanocarrier for overcoming to P-glycoprotein
Kaur, V., Garg, T., Rath, G., & Goyal, A. K. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2014.947295 · Cited by 43
Sithole, M. N., Choonara, Y. E., du Toit, L. C., Kumar, P., & Pillay, V. (2017) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2016.1212882 · Cited by 40
Yin, T., Zhang, Y., Liu, Y., Chen, Q., Fu, Y., Liang, J., Zhou, J., Tang, X., Liu, J., & Huo, M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.11.034 · Cited by 41
Schlachet, I., & Sosnik, A. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b04766 · Cited by 42
Harnessing the therapeutic potential of fisetin and its nanoparticles: Journey so far and road ahead
Vishwas, S., Singh, S. K., Gulati, M., Awasthi, A., Khursheed, R., Corrie, L., Kumar, R., Collet, T., Löebenberg, R., Porwal, O., et al. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109869 · Cited by 44
Peptide and Protein-Based Therapeutic Agents∗
Joseph, M. A., Trinh, H. M., & Mitra, A. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42978-8.00007-3 · Cited by 56
Raja, I. S., Thangam, R., & Fathima, N. N. (2018) · ACS Applied Bio Materials · doi:10.1021/acsabm.8b00526 · Cited by 41
Nano-antimicrobials: A New Paradigm for Combating Mycobacterial Resistance
Minakshi, P., Ghosh, M., Brar, B., Kumar, R., Lambe, U. P., Ranjan, K., Manoj, J., & Prasad, G. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190620094041 · Cited by 42
Hatem, S., Hoffy, N. M. E., Elezaby, R. S., Nasr, M., Kamel, A. O., & Elkheshen, S. A. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101984 · Cited by 42
Novel Pentablock Copolymers as Thermosensitive Self-Assembling Micelles for Ocular Drug Delivery
Alami-Milani, M., Zakeri‐Milani, P., Valizadeh, H., Salehi, R., Salatin, S., Naderinia, A., & Jelvehgari, M. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.003 · Cited by 40
Analysis and optimization of drug solubility to improve pharmacokinetics
Thapa, R. K., Choi, H., Kim, J. O., & Yong, C. S. (2017) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-016-0299-z · Cited by 38
Nanobased Intravenous and Transdermal Drug Delivery Systems
Rathna, G. V. N., Singam, A., & Killi, N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814029-1.00019-3 · Cited by 38
Polymeric micelles: a ray of hope among new drug delivery systems
Kapse, A., Anup, N., Patel, V., Saraogi, G. K., Mishra, D. K., & Tekade, R. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814487-9.00006-5 · Cited by 51
Alheibshy, F., Başaran, E., Arslan, R., Öztürk, N., Erol, K., & Demirel, M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119106 · Cited by 38
Singh, S., Sharma, N., Zahoor, I., Behl, T., Antil, A., Gupta, S., Anwer, M. K., Mohan, S., & BUNGAU, S. G. (2022) · Molecules · doi:10.3390/molecules28010220 · Cited by 39
Jadhav, A., & Nagaraj, K. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17060779 · Cited by 41
Chasara, R. S., Ajayi, T. O., Leshilo, D. M., Poka, M., & Witika, B. A. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19896 · Cited by 39
“They hold the potential to gain desired biopharma-ceutical and pharmacokinetic features of medications and boost their bioavailability because of their nanoscopic size, capacity to solubilise hydrophobic pharmaceuticals in high quantities, and ability to accomplish site-specific delivery [61].”
BackgroundSelf-assembled Micelle Loading Cabazitaxel for therapy of Lung Cancer
Zhuang, B. A., Du, L., Xu, H., Xu, X., Wang, C., Fan, Y., Cong, M., Yin, J., Li, H., & Guan, H. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.12.073 · Cited by 37
Amphiphilic block copolymers–based micelles for drug delivery
Imran, M., Shah, M. R., & Shafiullah (2018) · Design and Development of New Nanocarriers · doi:10.1016/b978-0-12-813627-0.00010-7 · Cited by 35
Singh, G., Singh, D. P., Choudhari, M. V., Kaur, S. D., Dubey, S. K., Arora, S., & Bedi, N. (2021) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-021-00540-0 · Cited by 35
Mondal, A. K., Das, S., Ali, S. M., Kolay, S., Sengupta, A., & Molla, M. R. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.2c00493 · Cited by 37
Sun, X. S., Jang, M.-S., Fu, Y., Lee, J. H., Lee, D. S., Li, Y., & Yang, H. Y. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111069 · Cited by 34
Wang, L., Yu, M., & Yang, H. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s304101 · Cited by 35
Development of pH-Responsive Polypills via Semi-Solid Extrusion 3D Printing
Wang, F., Li, L., Zhu, X., Chen, F., & Han, X. (2023) · Bioengineering · doi:10.3390/bioengineering10040402 · Cited by 38
“Oral compounded tablet delivery is popular among various drug delivery systems because of its ease of administration and low patient pain [1]; it has also been adopted by the World Health Organization (WHO) as a strategy for improving patient compliance [2,3].”
BackgroundKesharwani, S. S., Dachineni, R., Bhat, G. J., & Tummala, H. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101254 · Cited by 34
Nanoparticles for Drug Delivery
Tariq, A., Bhawani, S. A., & Moheman, A. (2019) · Advanced structured materials · doi:10.1007/978-981-13-9833-9_9 · Cited by 34
Ha, P. T., Nguyen, H. N., Do, H. D., Phan, Q. T., Thi, M. N. T., Nguyen, X. P., Thi, M. N. H., Le, M. H., Nguyen, L. T., Bui, T. Q., et al. (2016) · Advances in Natural Sciences Nanoscience and Nanotechnology · doi:10.1088/2043-6262/7/1/015001 · Cited by 33
Nanomicelles in Diagnosis and Drug Delivery∗
Trinh, H. M., Joseph, M. A., Cholkar, K., Mitra, R., & Mitra, A. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42978-8.00003-6 · Cited by 51
Macromolecules as targeted drugs delivery vehicles: an overview
Ali, Y., Alqudah, A. A., Ahmad, S. A., Hamid, S. A., & Farooq, U. (2019) · Designed Monomers & Polymers · doi:10.1080/15685551.2019.1591681 · Cited by 37
Srivastava, S., Kumar, A., Yadav, P. K., Kumar, M., Mathew, J., Pandey, A. C., & Chourasia, M. K. (2021) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2021.2007394 · Cited by 33
“Micelles have the potential to prolong drug circulation time, exert passive targeting effects, and prevent harmful adverse effects [16,17].”
BackgroundNoi, I., Schlachet, I., Kumarasamy, M., & Sosnik, A. (2018) · Polymers · doi:10.3390/polym10050478 · Cited by 34
“, polymeric micelles) are formed through the self-assembly of amphiphilic block or graft copolymers in a solvent that selectively solubilizes the hydrophilic blocks of the copolymer [22] and they have shown great potential for oral drug delivery [23-25].”
BackgroundFarooq, M. A., Aquib, M., Khan, D. H., Hussain, Z., Ahsan, A., Baig, M. M. F. A., Wande, D. P., Ahmad, M. M., Ahsan, H. M., Jiajie, J., et al. (2019) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-019-00308-w · Cited by 35
“These novel nanoparticles improved their circulation in blood stream over time, improved their accumulation in cancer cells and reduced the tumour size by 12-fold in tumour bearing BALB/c nude mice [60].”
BackgroundMehrotra, S., Pavan Kalyan, B. G., Nayak, P. G., Joseph, A., & Manikkath, J. (2023) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2024.009 · Cited by 44
“169 Liposomes may have difficulties reaching the target location of action due to their large size than the vascular cut-off size in some cancers.”
BackgroundAcyl and oligo(lactic acid) prodrugs for PEG-b-PLA and PEG-b-PCL nano-assemblies for injection
Repp, L., Rasoulianboroujeni, M., Lee, H. J., & Kwon, G. S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.008 · Cited by 33
Understanding the self-assembly of the polymeric drug solubilizer Soluplus®
Mateos, H., Gentile, L., Murgia, S., Colafemmina, G., Collu, M., Smets, J., & Palazzo, G. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.12.016 · Cited by 32
Nair, A. B., Dalal, P., Kadian, V., Kumar, S., Garg, M., Rao, R., Almuqbil, R. M., Alnaim, A., Al‐Dhubiab, B. E., & Alqattan, F. (2023) · Plants · doi:10.3390/plants12051168 · Cited by 39
Micelle-engineered nanoplatforms for precision oncology
Gao, W., Bigham, A., Ghomi, M., Zarrabi, A., Rabiee, N., Saeb, M. R., Ertaş, Y. N., Goel, A., Sharifi, E., Ashrafizadeh, M., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.153438 · Cited by 33
Mathavan, S., Chen‐Tan, N., Arfuso, F., & Al‐Salami, H. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1110846 · Cited by 31
“(Xu et al., 2013), with blood collection at various time”
MethodInfluentialNano- and microparticles as drug carriers
García, M. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102548-2.00004-4 · Cited by 35
Öztürk, K., Kaplan, M., & Çalış, S. (2020) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2020.1820037 · Cited by 31
Li, X., Liu, S., Wang, Q., & Lu, R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s87471 · Cited by 31
“In this respect, some versatile nanocarriers have shown the potential of protecting labile drugs, such as PEGylated lipid nanoparticles, 12,13 polymeric micelles or nanoparticles, 14–16 and liposomes.”
Comparative evaluation of porous silica based carriers for lipids and liquid drug formulations
Choudhari, Y. M., Reddy, U., Monsuur, F., Pauly, T., Hoefer, H., & McCarthy, W. (2014) · Open Material Sciences · doi:10.2478/mesbi-2014-0004 · Cited by 31
“, approximately 40% of the drugs are poorly water-soluble [3] and 70% of the newchemical entities possesswater solubility issues [4, 5], whichmay result in loworal bioavailability.”
BackgroundGao, P., Jiang, X. M., Li, J., Nicolas, J., & Ha‐Duong, T. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202503503 · Cited by 36
Chen, R.-J., Chen, P., Prasannan, A., Vinayagam, J., Huang, C., Chou, P.-Y., Weng, C.-C., Tsai, H., & Lin, S. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.03.034 · Cited by 30
Preparation and in vitro and in vivo evaluation of quercetin-loaded mixed micelles for oral delivery
Lü, Z., Bu, C., Hu, W., Zhang, H., Liu, M., Lu, M., & Zhai, G. (2018) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2017.1419852 · Cited by 31
Micelles in Cancer Therapy: An Update on Preclinical and Clinical Status
Kushwaha, P., Aqeel, R., & Srivastava, N. (2021) · Recent Patents on Nanotechnology · doi:10.2174/1872210515666210720125717 · Cited by 30
Promising Strategies of Colloidal Drug Delivery-Based Approaches in Psoriasis Management
Singh, S., Sharma, N., Behl, T., Sarkar, B. C., Saha, H. R., Garg, K., Singh, S. K., Arora, S., Amran, M. S., Abdellatif, A. A. H., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111978 · Cited by 33
“Polymeric micelle‐incorporated drugs reach systemic circulation faster and have more excellent ssembly i lymph nodes [112,113].”
BackgroundKaur, J., Gulati, M., Famta, P., Corrie, L., Awasthi, A., Saini, S., Khatik, G. L., Bettada, V. G., Madhunapantula, S. V., Paudel, K. R., et al. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121987 · Cited by 30
N-mercapto acetyl-N′-octyl-O, N″-glycol chitosan as an efficiency oral delivery system of paclitaxel
Huo, M., Fu, Y., Liu, Y., Chen, Q., Mu, Y., Zhou, J., Li, L., Xu, W., & Yin, T. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.10.066 · Cited by 30
Self-citationZhang, Y., Dong, K., Wang, F., Wang, H., Wang, J., Jiang, Z., & Diao, S. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.06.053 · Cited by 30
Pinyakit, Y., Palaga, T., Kiatkamjornwong, S., & Hoven, V. P. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01533g · Cited by 29
Functionalized nanomaterials for biomedical and agriculture industries
Chandra Kanth, P., Verma, S. K., & Gour, N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816787-8.00010-7 · Cited by 36
Pan, H., Yu, Y., Li, L., Liu, B., & Liu, Y. (2021) · Nanoscale Research Letters · doi:10.1186/s11671-021-03541-y · Cited by 29
“Many nanosized materials including liposomes [3], polymers [4], nanoparticles [5], dendrimers [6], micelles [7], and graphene oxide [8, 9] have been developed for the delivery of various drugs.”
BackgroundEvaluating parameters affecting drug fate at the intramuscular injection site
McCartan, A. J. S., Curran, D. W., & Mrsny, R. J. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.06.023 · Cited by 30
A review of nanotechnology with an emphasis on Nanoplex
Kadam, R. N., Shendge, R. S., & Pande, V. V. (2015) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502015000200002 · Cited by 28
Targeted delivery and controlled release of polymeric nanomedicines for tumor therapy
Shen, N., Zhao, W., Chu, H., Yu, H., Sun, H. Y., Tang, Z., & Chen, X. (2025) · Fundamental Research · doi:10.1016/j.fmre.2025.01.011 · Cited by 28
Vishwas, S., Kumar, R., Khursheed, R., Ramanunny, A. K., Kumar, R., Awasthi, A., Corrie, L., Porwal, O., Arshad, M. F., Alshammari, M. K., et al. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220810105421 · Cited by 31
“They offer significant drug loading and provide controlled release at the target sites [107, 108].”
BackgroundSoliman, G. M., Redón, R., Sharma, A., Mejía, D., Maysinger, D., & Kakkar, A. K. (2014) · Macromolecular Bioscience · doi:10.1002/mabi.201400123 · Cited by 28
Zhang, X., Wang, H., Zhang, T., Zhou, X., & Wu, B. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.06.008 · Cited by 30
“The hydrophobic core serves as a reservoir to solubilize drugs with poor aqueous solubility, whereas the hydrophilic shell has the ability to protect chemically unstable drugs from degradation (Xu et al., 2013).”
BackgroundSelf-citationMakhmalzadeh, B. S., Esfahani, G., & Salimi, A. (2018) · Molecules · doi:10.3390/molecules23081904 · Cited by 27
“Polymeric micelles demonstrate thermodynamic and kinetic stability upon dilution and preserve the stable core-shell structure in the gastrointestinal tract [31].”
Principles of nanosized drug delivery systems
Peltonen, L., Singhal, M., & Hirvonen, J. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102985-5.00001-2 · Cited by 32
Amphiphilic Peptide Nanorods Based on Oligo-Phenylalanine as a Biocompatible Drug Carrier
Song, S. J., Lee, S., Ryu, K., & Choi, J. S. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00247 · Cited by 28
Metadata
- Authors
- Xu, W., Ling, P., & Zhang, T.
- Affiliations
- Shandong University (CN)
- Institute of Biopharmaceuticals of Shandong Province, Jinan 250101, China
- Corresponding author
- Ling, Peixue
- ORCID
- Venue
- Journal of Drug Delivery
- Publisher
- Wiley
- Published
- 2013-06-27
- Volume
- 2013
- Pages
- 1-15
- ISSN
- 2090-3014 (ISSN-L)
- 2090-3022
- PMC
- PMC3712247
- OpenAlex
- W2061955697
- Cited by
- 595
- References
- 181
- Citations by year
- 2026: 32 · 2025: 47 · 2024: 50 · 2023: 60 · 2022: 74 · 2021: 70 · 2020: 56 · 2019: 49 · 2018: 41 · 2017: 43 · 2016: 32 · 2015: 22 · 2014: 18 · 2013: 1
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Drug Delivery (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- University of California, Davis
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- polymeric micelles, oral drug delivery, bioavailability enhancement, poorly water-soluble drugs, mucoadhesion, pH-responsive micelles, controlled drug release, P-glycoprotein inhibition, efflux pump inhibition, drug stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.